Infliximab - Janssen Biotech
At a glance
- Drug Originator NYU Langone Medical Center
- Drug Licenced by Merck & Co; Mitsubishi Tanabe Pharma Corporation; Ortho-McNeil Pharmaceutical
- Drug Class Anti-inflammatories; Anti-TNF monoclonal antibodies; Antipsoriatics; Antirheumatics
- Mechanism of Action Tumour necrosis factor alpha inhibitors
- USA Patent Applicants CENTOCOR INC
- USA Patents 516
- BLAs 1
- International Patents 6,869
Disclaimer